NOW AVAILABLE: SPARCL Universal Pharmacokinetic Kit

For assay developers requiring a high performance kit, the SPARCL Universal Pharmacokinetic Kit (SPARCL UPK) is the first high performance kit specially designed for drug quantification for all IgG subclasses in all major preclinical species.

The SPARCL UPK includes the SPARCL chemistry and the antibodies needed to develop pharmacokinetic (PK) assays for human IgG1, IgG2, IgG3 and IgG4 drugs from species that include mouse, rat, dog, rabbit and non-human primate.

For SPARCL UPK Ordering Information

NOW AVAILABLE through Life Diagnostics: SPARCL KITS

Lumigen has partnered with Life Diagnostics, Inc. to provide additional SPARCL Kits for our customers. Click here for more information on the current SPARCL Kits available through Life Diagnostics.

Chemistry that brings meaning to light.

Lumigen is one of the world's largest suppliers of chemiluminescent reagents to the clinical immunodiagnostics market. Lumigen researches, develops, manufactures and markets novel chemiluminescent compounds for use in life science research and medical diagnostics.

Lumigen chemiluminescent reagents are used worldwide in automated systems for the chemiluminescent detection of alkaline phosphatase conjugates and for ultra-sensitive chemiluminescent ELISA assays and Western blotting detection of horseradish peroxidase conjugates in life science research.

At Lumigen, the goal is to continually be at the forefront of the development of innovative new detection technologies for the clinical laboratory and life science research communities. This commitment to innovation is reflected in the current generation of products and in the development of other exciting new technologies currently under way.